☰

Jamie N. Sutherland, Ph.D. - Publications

Affiliations: 
2010 University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
discovery and development of protein therapeutics and applied immunology by capitalizing on state of the art protein engineering, directed evolution and systems biology technologies
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Acquaye-Seedah E, Huang Y, Sutherland JN, DiVenere AM, Maynard JA. Humanized monoclonal antibodies neutralize pertussis toxin by receptor blockade and reduced retrograde trafficking. Cellular Microbiology. e12948. PMID 30152075 DOI: 10.1111/Cmi.12948  0.628
2012 Im H, Sutherland JN, Maynard JA, Oh SH. Nanohole-based surface plasmon resonance instruments with improved spectral resolution quantify a broad range of antibody-ligand binding kinetics. Analytical Chemistry. 84: 1941-7. PMID 22235895 DOI: 10.1021/Ac300070T  0.572
2011 Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization. Clinical and Vaccine Immunology : Cvi. 18: 954-62. PMID 21508166 DOI: 10.1128/Cvi.00561-10  0.6
2009 Maynard JA, Lindquist NC, Sutherland JN, Lesuffleur A, Warrington AE, Rodriguez M, Oh SH. Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins. Biotechnology Journal. 4: 1542-58. PMID 19918786 DOI: 10.1002/Biot.200900195  0.48
2009 Sutherland JN, Maynard JA. Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7. Biochemistry. 48: 11982-93. PMID 19899804 DOI: 10.1021/Bi901532Z  0.595
2009 Pai JC, Sutherland JN, Maynard JA. Progress towards recombinant anti-infective antibodies. Recent Patents On Anti-Infective Drug Discovery. 4: 1-17. PMID 19149692 DOI: 10.2174/157489109787236319  0.597
Show low-probability matches.